AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The Gut and Skin Microbiome in Vitiligo Disease Progression

Recruitingn/aAges 18 Years - 89 YearsAllNorthwestern University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of patients with vitiligo differs from the general population.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients with and/or without vitiligo lesional expansion over the past year. * Age/sex-matched controls who do not have a diagnosis of vitiligo * Subjects who are age 18-89 years of age at time of enrollment * Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443) Exclusion Criteria: * Subjects who are younger than 18 years of age or 90 years of age or older * Subjects who are unable to give consent
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Northwestern University
Chicago, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy